Advertisement

Angiotensin II AT1 receptor blockade normalizes CD11b+ monocyte production in bone marrow of hypercholesterolemic monkeys

  • William B. Strawn
    Correspondence
    Corresponding author at: Hypertension and Vascular Research Center, Wake Forest University Health Sciences, Medical Center Blvd., Winston-Salem, NC 27157, United States. Tel.: +1 336 716 9524; fax: +1 336 716 6644.
    Affiliations
    Hypertension and Vascular Research Center, Wake Forest University Health Sciences, Winston-Salem, NC, United States
    Search for articles by this author
  • Carlos M. Ferrario
    Affiliations
    Hypertension and Vascular Research Center, Wake Forest University Health Sciences, Winston-Salem, NC, United States
    Search for articles by this author

      Abstract

      The enhanced production of monocytes expressing pro-inflammatory markers such as the integrin CD11b in patients with hypercholesterolemia may promote vascular inflammation and exacerbate atherogenesis. The objective of the present study was to determine whether hypercholesterolemia stimulates the production of CD11b+ monocytes in bone marrow, and whether the renin–angiotensin system participates in this process and thus provides a target for therapeutic intervention. The dietary induction of hypercholesterolemia in adult male cynomolgus monkeys was accompanied by increased bone marrow cellularity and elevated peripheral blood and bone marrow monocyte CD11b expression. Isolated bone marrow CD34+ hematopoietic stem cells (HSCs) evaluated by in vitro functional assays exhibited enhanced myeloproliferative capacity and differentiation into CD11b+ monocytes. Treatment of hypercholesterolemic monkeys with the angiotensin II AT1 receptor blocker losartan for 15 weeks reduced bone marrow cellularity, suppressed peripheral blood and bone marrow monocyte CD11b expression, and normalized CD34+ cell function assays. All variables returned to pretreatment levels 6 weeks after discontinuation of losartan treatment. Hypercholesterolemia was associated with increased CD34+ cell AT1 receptor expression and an exaggerated in vitro myeloproliferative response to angiotensin II stimulation that positively correlated to plasma LDL concentrations. In vitro exposure to native low-density lipoproteins (LDL) also increased CD34+ cell AT1 receptor expression and the myeloproliferative response to angiotensin II stimulation in a dose-dependent and receptor-mediated manner. Our data provide support for a positive regulatory role of plasma LDL on AT1 receptor-mediated HSC differentiation and the production of pro-atherogenic monocytes. LDL-regulated HSC function may explain in part hypercholesterolemia-induced inflammation as well as the anti-inflammatory and anti-atherosclerotic effects of AT1 receptor blockers.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Weber C.
        • Erl W.
        • Weber K.S.
        • Weber P.C.
        HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia.
        J Am Coll Cardiol. 1997; 30: 1212-1217
        • Strehlow K.
        • Wassmann S.
        • Bohm M.
        • Nickenig G.
        Angiotensin AT1 receptor over-expression in hypercholesterolaemia.
        Ann Med. 2000; 32: 386-389
        • Mateo T.
        • bu Nabah Y.N.
        • Abu T.M.
        • et al.
        Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines.
        J Immunol. 2006; 176: 5577-5586
        • Khan B.V.
        • Navalkar S.
        • Khan Q.A.
        • Rahman S.T.
        • Parthasarathy S.
        Irbesartan, an angiotensin type 1 receptor inhibitor, regulates the vascular oxidative state in patients with coronary artery disease.
        J Am Coll Cardiol. 2001; 38: 1662-1667
        • Strawn W.B.
        • Chappell M.C.
        • Dean R.H.
        • Kivlighn S.
        • Ferrario C.M.
        Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia.
        Circulation. 2000; 101: 1586-1593
        • Cassis L.A.
        • Rateri D.L.
        • Lu H.
        • Daugherty A.
        Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms.
        Arterioscler Thromb Vasc Biol. 2007; 27: 380-386
        • Nishida M.
        • Fujinaka H.
        • Matsusaka T.
        • et al.
        Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis.
        J Clin Invest. 2002; 110: 1859-1868
        • Rodgers K.E.
        • Xiong S.
        • Steer R.
        • diZerega G.S.
        Effect of angiotensin II on hematopoietic progenitor cell proliferation.
        Stem Cells. 2000; 18: 287-294
        • Averill L.E.
        • Meagher R.C.
        • Gerrity R.G.
        Enhanced monocyte progenitor cell proliferation in bone marrow of hyperlipemic swine.
        Am J Pathol. 1989; 135: 369-377
        • Feldman D.L.
        • Mogelesky T.C.
        • Liptak B.F.
        • Gerrity R.G.
        Leukocytosis in rabbits with diet-induced atherosclerosis.
        Arterioscler Thromb. 1991; 11: 985-994
        • Nickenig G.
        • Wassmann S.
        • Bohm M.
        Regulation of the angiotensin AT1 receptor by hypercholesterolaemia.
        Diabetes Obes Metab. 2000; 2: 223-228
        • John S.
        • Delles C.
        • Klingbeil A.U.
        • et al.
        Low-density lipoprotein-cholesterol determines vascular responsiveness to angiotensin II in normocholesterolaemic humans.
        J Hypertens. 1999; 17: 1933-1939
        • Nickenig G.
        • Sachinidis A.
        • Michaelsen F.
        • et al.
        Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells.
        Circulation. 1997; 95: 473-478
        • Ettinger W.H.
        • Dysko R.C.
        • Clarkson T.B.
        Prednisone increases low density lipoprotein in cynomolgus monkeys fed saturated fat and cholesterol.
        Arteriosclerosis. 1989; 9: 848-855
        • Yasar U.
        • Forslund-Bergengren C.
        • Tybring G.
        • et al.
        Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype.
        Clin Pharmacol Ther. 2002; 71: 89-98
        • Shibata H.
        • Hanazono Y.
        • Ageyama N.
        • et al.
        Collection and analysis of hematopoietic progenitor cells from cynomolgus macaques (Macaca fascicularis): assessment of cross-reacting monoclonal antibodies.
        Am J Primatol. 2003; 61: 3-12
        • Duvillard L.
        • Florentin E.
        • Lizard G.
        • et al.
        Cell surface expression of LDL receptor is decreased in type 2 diabetic patients and is normalized by insulin therapy.
        Diabetes Care. 2003; 26: 1540-1544
        • Rasini E.
        • Cosentino M.
        • Marino F.
        • et al.
        Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study.
        Regul Pept. 2006; 134: 69-74
        • Drouet M.
        • Mourcin F.
        • Grenier N.
        • et al.
        Single administration of stem cell factor, FLT-3 ligand, megakaryocyte growth and development factor, and interleukin-3 in combination soon after irradiation prevents nonhuman primates from myelosuppression: long-term follow-up of hematopoiesis.
        Blood. 2004; 103: 878-885
        • Kansas G.S.
        • Muirhead M.J.
        • Dailey M.O.
        Expression of the CD11/CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation in humans.
        Blood. 1990; 76: 2483-2492
        • Winter S.S.
        • Sweatman J.J.
        • Larson R.S.
        Improved quantification of cell survival on stromal monolayers by flow cytometric analyses.
        Cytometry. 2000; 40: 26-31
        • Krizanac-Bengez L.
        • Moore P.F.
        • Barsoukov A.
        • Sandmaier B.M.
        The expression and differentiation pattern of cell antigens and adhesion molecules on the nonadherent cell population in canine long-term marrow culture: a biphasic development of myeloid and lymphoid cells.
        Tissue Antigens. 1998; 51: 141-155
        • Poumay Y.
        • Ronveaux-Dupal M.F.
        Rapid preparative isolation of concentrated low density lipoproteins and of lipoprotein-deficient serum using vertical rotor gradient ultracentrifugation.
        J Lipid Res. 1985; 26: 1476-1480
        • Han K.H.
        • Chen Y.
        • Chang M.K.
        • et al.
        LDL activates signaling pathways leading to an increase in cytosolic free calcium and stimulation of CD11b expression in monocytes.
        J Lipid Res. 2003; 44: 1332-1340
        • Miyazaki M.
        • Takai S.
        Anti-atherosclerotic efficacy of olmesartan.
        J Hum Hypertens. 2002; 16: S7-S12
        • Brunet dlG
        • Ivanovic Z.
        • Leprivey-Lorgeot V.
        • Praloran V.
        Angiotensin II that reduces the colony-forming ability of hematopoietic progenitors in serum free medium has an inverse effect in serum-supplemented medium.
        Stem Cells. 2002; 20: 269-271
        • Aye M.T.
        • Seguin J.A.
        • McBurney J.P.
        Erythroid and granulocytic colony growth in cultures supplemented with human serum lipoproteins.
        J Cell Physiol. 1979; 99: 233-238
        • Strawn W.B.
        • Richmond R.S.
        • Ann T.E.
        • Gallagher P.E.
        • Ferrario C.M.
        Renin–angiotensin system expression in rat bone marrow haematopoietic and stromal cells.
        Br J Haematol. 2004; 126: 120-126
        • Sinha A.K.
        • Mehta J.L.
        Modulation of atherosclerosis, blood pressure and arterial elasticity by statins.
        Adv Cardiol. 2007; 44: 315-330
        • Nickenig G.
        • Baumer A.T.
        • Temur Y.
        • et al.
        Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men.
        Circulation. 1999; 100: 2131-2134